Free Content Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus

Authors: Uusimaa, Johanna; Hinttala, Reetta; Rantala, Heikki1; Päivärinta, Markku2; Herva, Riitta3; Röyttä, Matias4; Soini, Heidi; Moilanen, Jukka S.; Remes, Anne M.; Hassinen, Ilmo E.5; Majamaa, Kari

Source: Epilepsia, Volume 49, Number 6, June 2008 , pp. 1038-1045(8)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Summary

Purpose: Polymerase gamma (POLG) is the sole enzyme in the replication of mitochondrial DNA (mtDNA). Numerous mutations in the POLG1 gene have been detected recently in patients with various phenotypes including a classic infantile-onset Alpers-Huttenlocher syndrome (AHS). Here we studied the molecular etiology of juvenile-onset AHS manifesting with status epilepticus and liver disease in three teenagers.

Patients and Methods: We examined 14- and 17-year-old female siblings (patients 1 and 2) and an unrelated 15-year-old girl (patient 3) with juvenile-onset AHS, sequenced POLG1, and the entire mtDNA, examined mtDNA deletions by amplification of the full-length mtDNA with the long PCR method and used real-time PCR to quantify mtDNA in the tissue samples.

Results: The initial manifestations were migraine-like headache and epilepsy, and the terminal manifestations status epilepticus and hepatic failure. A homozygous W748S mutation in POLG1 was detected in the three patients. No deletions or pathogenic point mutations were found in mtDNA, but all three patients had mtDNA depletion.

Conclusions: POLG mutations should be considered in cases of teenagers and young adults with a sudden onset of intractable seizures or status epilepticus, and acute liver failure. The W748S POLG1 mutation seems to lead to tissue-specific, partial mtDNA depletion in patients with juvenile-onset Alpers syndrome. Valproic acid should be avoided in the treatment of epileptic seizures in these patients.

Keywords: Status epilepticus; Metabolic diseases; Mitochondrial diseases; Genetic diseases

Document Type: Research article

DOI: 10.1111/j.1528-1167.2008.01544.x

Affiliations: 1: Department of Pediatrics, University of Oulu, Oulu, Finland 2: Department of Neurology, University of Turku, Turku, Finland 3: Department of Pathology, University of Oulu, Oulu, Finland 4: Department of Pathology, University of Turku, Turku, Finland 5: Department of Medical Biochemistry and Molecular Biology, University of Oulu, Oulu, Finland[Correction added after online publication Feb. 20, 2008: The affiliation: Jukka S. Moilanen, †Clinical Research Center, Oulu University Hospital, Oulu, Finland; **Department of Clinical Genetics, University of Turku, Turku, Finland has been changed to: Jukka S. Moilanen, †Clinical Research Center, Oulu University Hospital, Oulu, Finland; **Department of Clinical Genetics, University of Oulu, Oulu, Finland]

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A